Related Experiment Video
Updated: Jun 25, 2026

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
Docking of oxalyl aryl amino benzoic acid derivatives into PTP1B
Neelam Verma1, Minakshi Mittal, Raman Kumar Verma
1Department of Biotechnology, Punjabi University, Patiala. neelam_verma2@rediffmail.com
Abstract:
Protein Tyrosine Phosphatases (PTPs) that function as negative regulators of the insulin signaling cascade have been identified as novel targets for the therapeutic enhancement of insulin action in insulin resistant disease states. Reducing Protein Tyrosine Phosphatase1B (PTP1B) abundance not only enhances insulin sensitivity and improves glucose metabolism but also protects against obesity induced by high fat feeding. PTP1B inhibitors such as Formylchromone derivatives, 1, 2-Naphthoquinone derivatives and Oxalyl aryl amino benzoic derivatives may eventually find an important clinical role as insulin sensitizers in the management of Type-II Diabetes and metabolic syndrome. We have carried out docking of modified oxalyl aryl amino benzoic acid derivatives into three dimensional structure of PTP1B using BioMed CAChe 6.1. These compounds exhibit good selectivity for PTP1B over most of phosphatases in selectivity panel such as SHP-2, LAR, CD45 and TCPTP found in literature. This series of compounds identified the amino acid residues such as Gly220 and Arg221 are important for achieving specificity via H-bonding interactions. Lipophilic side chain of methionine in modified oxalyl aryl amino benzoic acid derivative [1b (a2, b2, c1, d)] lies in closer vicinity of hydrophobic region of protein consisted of Meth258 and Phe52 in comparison to active ligand. Docking Score in [1b (a2, b2, c1, d)] is -131.740Kcal/mol much better than active ligand score -98.584Kcal/mol. This information can be exploited to design PTP1B specific inhibitors.
Insights
Novel oxalyl aryl amino benzoic acid derivatives show promise as selective inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B). These compounds enhance insulin sensitivity and could be valuable in treating type-II diabetes and metabolic syndrome.
Area of Science:
- Biochemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Protein Tyrosine Phosphatases (PTPs) are key regulators of insulin signaling.
- PTP1B is a validated therapeutic target for enhancing insulin action in insulin resistance, obesity, and type-II diabetes.
- Inhibiting PTP1B improves insulin sensitivity and glucose metabolism.
Purpose of the Study:
- To design and evaluate novel oxalyl aryl amino benzoic acid derivatives as selective PTP1B inhibitors.
- To investigate the molecular interactions responsible for PTP1B inhibition and selectivity.
- To identify potential insulin sensitizers for metabolic diseases.
Main Methods:
- Molecular docking of modified oxalyl aryl amino benzoic acid derivatives into the PTP1B structure using BioMed CAChe 6.1.
- Assessment of selectivity against other phosphatases (SHP-2, LAR, CD45, TCPTP).
- Analysis of key amino acid residues (Gly220, Arg221) and hydrophobic interactions (Meth258, Phe52) for specificity.
Main Results:
- The modified oxalyl aryl amino benzoic acid derivatives demonstrated good selectivity for PTP1B.
- Hydrogen bonding interactions with Gly220 and Arg221 were identified as crucial for specificity.
- Derivative [1b (a2, b2, c1, d)] exhibited a significantly better docking score (-131.740 Kcal/mol) compared to the active ligand (-98.584 Kcal/mol).
- Hydrophobic interactions of the derivative's methionine side chain with PTP1B residues Meth258 and Phe52 were observed.
Conclusions:
- Oxalyl aryl amino benzoic acid derivatives are effective PTP1B inhibitors with high selectivity.
- The identified interactions provide a basis for designing more potent and specific PTP1B inhibitors.
- These compounds hold potential as therapeutic agents for type-II diabetes and metabolic syndrome.
Related Concept Videos
Tail-anchoring of Proteins in the ER Membrane
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
